Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) Consolidated Net Income (2022 - 2025)

Historic Consolidated Net Income for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to -$6.2 million.

  • Envoy Medical's Consolidated Net Income fell 1800.99% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.4 million, marking a year-over-year decrease of 249.28%. This contributed to the annual value of -$20.1 million for FY2024, which is 933.06% down from last year.
  • Per Envoy Medical's latest filing, its Consolidated Net Income stood at -$6.2 million for Q3 2025, which was down 1800.99% from -$5.7 million recorded in Q2 2025.
  • Envoy Medical's Consolidated Net Income's 5-year high stood at $12.5 million during Q1 2022, with a 5-year trough of -$6.7 million in Q4 2023.
  • Over the past 4 years, Envoy Medical's median Consolidated Net Income value was -$4.9 million (recorded in 2024), while the average stood at -$1.9 million.
  • Within the past 5 years, the most significant YoY rise in Envoy Medical's Consolidated Net Income was 2662.5% (2024), while the steepest drop was 78552.22% (2024).
  • Over the past 4 years, Envoy Medical's Consolidated Net Income (Quarter) stood at -$2.0 million in 2022, then plummeted by 234.69% to -$6.7 million in 2023, then grew by 26.63% to -$4.9 million in 2024, then dropped by 25.26% to -$6.2 million in 2025.
  • Its Consolidated Net Income was -$6.2 million in Q3 2025, compared to -$5.7 million in Q2 2025 and -$5.6 million in Q1 2025.